Safety and Efficacy of the LVIS and LVIS JR Devices in the Endovascular Treatment of Intracranial Aneurysms
NCT ID: NCT03553771
Last Updated: 2024-01-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
130 participants
OBSERVATIONAL
2018-02-07
2021-07-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Pivotal Study of the LVIS (Low Profile Visualized Intraluminal Support)
NCT01793792
Feasibility Study of the LVIS™ (Low-profile Visualized Intraluminal Support)Device
NCT01541254
Efficacy and Safety of the Self-expanding Intracranial Stent (Tonbridge) for Endovascular Treatment of Intracranial Aneurysms
NCT05755516
LVIS™ Evo™ and HydroCoil® Embolic System for Intracranial Aneurysm Treatment
NCT04999423
TRAIL: Treatment of Intracranial Aneurysms With LVIS® System
NCT02921711
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The purpose of this study is to collect data on safety of the devices used since the French reimbursement.
130 patients will be enrolled over an 18-month recruitment period. All patients will be followed for at least 12 months.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
LVIS and LVIS JR
Braided coil assist stents used for aneurysm embolization
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patient or patient's legally authorized representative has been informed about the study and does not oppose the collection of his/her personal data
Exclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Clinact
OTHER
Microvention-Terumo, Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Michel Piotin, MD
Role: PRINCIPAL_INVESTIGATOR
Fondation Rothschild, Paris, France
Charbel Mounayer, Prof.
Role: PRINCIPAL_INVESTIGATOR
CHU de Limoges, France
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU Pellgrin
Bordeaux, , France
CHU Caen
Caen, , France
CHU Gabriel Montpied
Clermont-Ferrand, , France
CHU Michallon
Grenoble, , France
Hôpital Bicêtre
Le Kremlin-Bicêtre, , France
CHU Limoges
Limoges, , France
Hôpital Clairval
Marseille, , France
Hôpital de la Timone
Marseille, , France
Hôpital Gui de Chauliac
Montpellier, , France
Hôpital Central de Nancy
Nancy, , France
Hôpital Pasteur 2
Nice, , France
Hôpital Lariboisière
Paris, , France
Hôpital Pitié-Salpêtrière
Paris, , France
La Fondation Rothschild
Paris, , France
Hôpital Maison Blanche
Reims, , France
Hôpital Nord
Saint-Etienne, , France
Hôpital Foch
Suresnes, , France
Hôpital d'instruction des Armées Saint-Anne
Toulon, , France
Hôpital Purpan
Toulouse, , France
Hôpital Bretonneau
Tours, , France
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Forestier G, Piotin M, Chau Y, Derelle AL, Brunel H, Aggour M, Saleme S, Levrier O, Pierot L, Barreau X, Boubagra K, Janot K, Barbier C, Clarencon F, Chabert E, Spelle L, Arteaga C, Consoli A, Machi P, Blanc R, Rodesch G, Cortese J, Sourour N, Herbreteau D, Heck O, Soize S, Marnat G, Rouchaud A, Anxionnat R, Sedat J, Mounayer C; LEPI investigators. Safety and effectiveness of the LVIS and LVIS Jr devices for the treatment of intracranial aneurysms: Final results of the LEPI multicenter cohort study. J Neuroradiol. 2024 May;51(3):242-248. doi: 10.1016/j.neurad.2023.10.007. Epub 2023 Oct 17.
Related Links
Access external resources that provide additional context or updates about the study.
Safety and effectiveness of the LVIS and LVIS Jr devices for the treatment of intracranial aneurysms: Final results of the LEPI multicenter cohort study
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
LEPI
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.